Fibrillar collagen is a critical component of atherosclerotic lesions. Uncontrolled collagen accumulation leads to arterial stenosis, while excessive collagen breakdown combined with inadequate synthesis weakens plaques thereby making them prone to rupture. This review discusses cellular sources of collagen synthesis in atherosclerosis, local and systemic factors modulating collagen gene expression, as well as temporal and spatial patterns of collagen production in human and experimental atherosclerotic lesions.
1. Collagen the good, the bad and the ugly reinforcement leads to plaque weakness and vulnerability [17, 18] . Thus ''too much'' collagen leads to arterial Collagens are proteins that consist of a triple helix of stenosis, while ''not enough'' collagen makes atherospolypeptide chains and globular domains. Collagens comclerotic plaque prone to rupture. prise a family of proteins of at least 19 genetically distinct Collagen content is a net result of dynamic balance types [1, 2] . Human atherosclerotic plaques contain mostly between degradation and synthesis. Collagen degradation interstitial collagen types I and III [3] , and type I collagen in atherosclerosis has become a subject of recent reviews comprises approximately two-thirds of the total collagen [17, 19] . This review is focused on collagen synthesis, [4] . Type V collagen also increases in advanced atherosspecifically production of type I and III collagen. Fibrillar clerotic plaques [5] . Thick type IV collagen depositions are collagens are highlighted because they play a major role in frequently seen in the fibrous cap regions [3, 5, 6] . This both plaque growth and mechanical stability. correlates with observation of SMCs surrounded by concentric layers of basement membrane material [7] .
Collagen constitutes up to 60% of the total plaque 2. Principles of collagen biosynthesis protein [8] thus contributing to the plaque growth and the arterial lumen narrowing. It may also stimulate further Collagen type I is the product of two different genes, lesion progression by serving as a depot for proa (I) and a (I), which are coordinately regulated. Col- 1 2 atherogenic molecules: modified lipoproteins [9] , growth lagen type III is the product of one gene, a (III). Tran-1 factors [10] and glycation end-products [11] . Collagen can scriptional regulation of type I collagen genes is more modulate macrophage functions [12] , SMC proliferation thoroughly characterized [20, 21] . Regulatory elements [13] , migration [14] and responsiveness to growth factors located in the promoter and 59 flanking region and the first [15] , and stimulate thrombus formation [16] . Fibrillar and fifth introns of the human and mouse a (I) collagen 1 collagen also contributes to plaque structural integrity and genes have been identified (recently reviewed in [22, 23] . mechanical ''strength''. Therefore, a deficit of collagen Several transcription factors interacting with the proximal [24, 25] , it is unknown if in plaque of cell proliferative state (for review see [32] ). In primary cells this activation requires a specific ''signature'' of ciscultures of adult rat and rabbit aortic SMCs, the transition and trans-elements.
into a synthetic phenotype was found to be accompanied Collagen biosynthesis involves a large number of cotby an increase in collagen secretion [33] [34] [35] . In subculranslational and post-translational events [26] . The intured cells, the levels of collagen synthesis were found to tracellular events include formation of pro-a-chains, hyshow either positive [36, 37] or negative [38] [39] [40] correladroxylation, glycosylation, assembly and secretion. Extion with SMC proliferation. Transcription factor B-myb tracellular events include cleavage of procollagen molerepresents a potential link in the observed inverse relationcules, formation of collagen fibrils and cross-linking.
ships [40] . Classical steps of collagen biosynthesis have been reWe correlated cell proliferation and collagen synthesis in viewed in detail [27] and will not be discussed here.
human atherosclerotic material [41] . We have demonstraCollagen production may be controlled at several levels:
ted, that although proliferation and type I collagen gene (1) transcription, (2) mRNA stability, (3) biosynthesis and expression could occur in the same cell, this is a rare activity of each enzyme involved into collagen processing event, and the vast majority of collagen-producing cells do and assembly. Abundant phenomenological data on the not show proliferative activity (Fig. 2) . regulation of collagen synthesis in atherosclerosis (see Collagen synthesis is associated with SMC migration. In Section 3) often fail to pinpoint molecular mechanisms of observed changes.
Factors modulating collagen synthesis
Regulation of collagen synthesis is dependent on the intrinsic properties of the cell as well as extrinsic local and systemic factors. Three specific questions will be addressed here: (1) Which cells make collagen in atherosclerotic plaques? (2) Do cell migration and proliferation affect collagen production? (3) How do chemical and physical factors of atherosclerotic milieu influence collagen synthesis?
Cell types
It is assumed that the bulk of plaque collagen is produced by the smooth muscle cells (SMCs). However, collagens can be also produced by endothelial cells [28] . activity is contributed by endothelial cells [24] . It is also muscle cell; Mac, macrophage.
at Pennsylvania State University on http://cardiovascres.oxfordjournals.org/ Downloaded from type II TGF-b1 receptor gene has been discovered in human atherosclerotic and restenotic vascular cells [49] . Such receptor-variant cells could overproduce collagen.
Platelet-derived growth factor (PDGF-BB) also stimulates synthesis of type I and III collagen in SMC culture [42] . Transfer of PDGF-B gene stimulates type I collagen production in pig artery [50] . However, some investigators believe that PDGF is not a direct stimulant of collagen synthesis but rather a mitogen for cells, that subsequently synthesize collagen [51] . Interleukin-1 (IL-1) modestly increases the synthesis of collagens I and III [42] . Endothelin-1 [52] and angiotensin-II [53] stimulate collagen synthesis in SMC culture.
In contrast, basic fibroblast growth factor was reported to inhibit both spontaneous [54] [55] [56] [57] and TGF-b stimulated [44] collagen production by cultured SMCs. Transforming growth factor alpha also inhibits TGF-b induced collagen TGF-b-stimulated collagen synthesis by human SMCs in culture [42] . The antifibrotic effects of IFN-g have been vitro inhibition of collagen synthesis affected clustering of demonstrated in vivo. When atherosclerosis-prone ApoEb1 integrins on the surface of SMCs, impaired recruitment deficient mice were crossed with IFN-g receptor-knock-out of vinculin into focal adhesion complexes of spreading mice, the mice exhibited a reduction in atherosclerotic SMCs and disassembly of the smooth muscle cytoskeleton, lesion size, but a marked increase in lesion collagen which inhibited SMC spreading and slowed SMC migracontent [60] . IFN-g also has been shown to inhibit intimal tion [14] . These findings implicate a mechanism whereby thickening in the rat carotid balloon injury model [61, 62] . newly synthesized collagen may be necessary to maintain Extracellular matrix itself controls collagen synthesis in the transcellular traction system required for effective SMC culture. SMCs produced less collagen on fibronectinlocomotion. Thus collagen synthesis facilitates SMC micoated surfaces compared with cells grown on albumingration. It is unknown though whether cell migration is coated dishes [63] . Cells seeded on top or within a sufficient for induction or stimulation of collagen procollagen gel showed a suppressed collagen synthesis duction.
compared with cells grown directly on plastic [64] ; this suggests an autoregulatory mechanism. The steady-state 3.3. Local factors (Fig. 2) levels of a (I) and a (III) collagen mRNA of cells within 1 1 collagen lattices were higher that those grown on plastic, In SMC culture, transforming growth factor beta (TGFalthough the production of collagen was lower [65] . These b) is the most potent and consistent stimulator of collagen data suggest the involvement of post-translational control synthesis [39, [42] [43] [44] . TGF-b1 induces overproduction of of collagen production in collagen lattice-cultured SMCs. collagen in a rat balloon injury model [45] . In vivo transfer It has been also demonstrated, that preexisting collagen of TGF-b1 gene into pig artery stimulated type I collagen matrix may modulate growth factor-induced collagen production and accumulation [46] . TGF-b may elicit its synthesis. effects both directly and indirectly. A direct mechanism is Mechanical stretch can stimulate collagen synthesis by suggested by the presence of a TGF-b activation element cultured SMCs [66] [67] [68] or whole artery segments [69, 70] in the promoter of the a (I) gene [22] . Indirect effects of and may thus be a link between local hemodynamic forces 1 TGF-b may be mediated by connective tissue growth and plaque collagen production. The stretch-induced colfactor [47] . TGF-b activity also depends on receptor lagen synthesis appears to be mediated via an autocrineexpression. Normal human SMCs are growth-inhibited by paracrine mechanism of angiotensin II and TGF-b released TGF-b, and show little induction of collagen synthesis, yet from SMCs [71] . cells isolated from human atherosclerotic lesions are growth stimulated by TGF-b and markedly increase collagen synthesis [48] . Normal human SMCs express type I, 3.4. Systemic factors (Fig. 2 ) II and III TGF-b1 receptors. The type II receptor is decreased in lesion cells [48] . Genomic instability in the Ironically, the level of circulating low density lipop-rotein-associated cholesterol (LDL-C) is widely used as a 4.2. Animal models predictor of both plaque growth [72] and rupture [73] In the rat carotid artery balloon injury model, after 2 collagen synthesis [76] . The LDL fraction had the same weeks, while cell proliferative activity is returning to effect as whole serum. On the contrary, serum from type control levels, the intima continues to enlarge [90] . Type I IIA hypercholesterolemic patients inhibited collagen proprocollagen mRNA levels showed an initial decrease at 2 duction by cultured human fetal aortic SMCs [77] . Similar days, significantly increased at 1 week, peaked at 2 weeks, results were demonstrated in analogous rabbit [78] and then diminished at 4 weeks after injury [91] . Cultured monkey [79] systems. Variable sources of cultured cells neointimal SMCs, obtained from rabbit aortas, exhibited and techniques of LDL or serum handling make comelevated type I and III collagen gene expression 15 weeks parison of these data difficult. Moreover, in vivo LDL-C is after balloon injury [92] . Thus during the short-lived mostly accumulated by macrophages, which drastically proliferative phase and predominantly thereafter much changes macrophage biology. Products of lipid-laden intimal enlargement is a result of extracellular matrix macrophages may influence ability of adjacent SMCs to expansion largely due to collagen. synthesize collagen. Thus, in vivo influences of LDL-C on collagen synthesis represent the result of complex direct and indirect interactions with SMCs and therefore not 5. Spatial patterns of collagen synthesis (Fig. 1 ) necessarily can be predicted by in vitro incubation of SMCs with LDL-C.
Plaque topography and collagen synthesis
Homocysteine is also a risk factor for atherosclerosis [80] . Cultured SMC treated with homocysteine at conType I and III collagen synthesis tends to be located in centrations observed in patients with hyperthe intima [24, 25, 31, 84, 85, 93] . We found that in advanced homocysteinemia had collagen synthesis rates as high as fibrous carotid and coronary plaques, type I procollagen-214% of control values [81] .
synthesizing cells were especially prevalent in fibrous cap At the same time, antiatherogenic effects of some and vascularized parts of the shoulder regions [24] . The systemic factors can be mediated by inhibition of collagen reason for clustering of collagen-producing cells is unsynthesis. Administration of an estrogen-progesteron known. Most likely, it reflects the concentration gradient of combination to intact female rabbits on an atherogenic diet various regulatory factors, although selection of ''fibinhibited collagen synthesis and retarded the development rogenic'' cells is also a possibility. of atherosclerosis [82] . Ovariectomy increased the synthesis of aortic collagen and development of atherosclero-5.2. Macrophages sis in rabbits on atherogenic diet, whereas the administration of estradiol to similarly manipulated rabbits inhibited A putative inflammatory link to collagen gene expresthis increase [83] sion in human atherosclerosis has been highlighted by Jaeger et al. [25] . They found higher collagen type I and III mRNAs in human intimas than in medias. [93] . An association between type I collagen gene expression and monocyte / Neither we nor others have found any type I collagen macrophages in human hypertensive pulmonary arteries producing cells in normal human arteries [24, 31, 84, 85] .
has also been demonstrated [94] . We also have detected The presence of type I procollagen cells has been recently higher type I collagen mRNA and type I procollagen reported in all types of human aortic lesions: |6% in initial protein expression in human carotid and coronary atheroslesions, |18% in fatty streaks and fibrolipid plaques and clerotic plaques that in normal coronary or internal mam-|7% in fibrous plaques [31] . Thus collagen synthesis mary arteries, but have not seen a spacial correlation with occurs very early in lesion development and may represent the presence of macrophages [24] . Jaeger et al. reported no the major mechanism of its progression.
collagen / macrophage association in human aortic coarcta-tions [95] . In addition, the rat carotid artery injury model (reviewed in [17] ). It can be therefore implied that fibrous does not exhibit significant numbers of macrophages, but it cap area would have a tendency to grow. The fate of a does show prominent collagen gene expression. Thus, shoulder region is unpredictable, since two conflicting macrophages may be involved in, but are not necessary for processes (degradation and synthesis) are colocalized. collagen synthesis.
However, with any given rate of degradation, the less the rate of collagen synthesis, the more vulnerable the plaque. There are two major potentials for inadequate collagen 5.3. T cells synthesis in the plaque shoulders: (1) high concentration of the inhibitors of collagen synthesis, like T-cell derived Our morphometric analysis revealed strong negative IFN-g; (2) local depletion of the cellular source of association between plaque regions displaying type I collagen synthesis, i.e. SMC death. Both processes do in collagen gene expression and the presence of T cells, fact take place in human atherosclerotic plaques [98, 99] . suggesting that T cell mediators such as IFN-g [42] inhibit
We have recently developed an animal model of atherocollagen synthesis in human atherosclerosis.
sclerosis, where the plaque is formed around inflatable balloon and can be ruptured at will [100] . We have 5.4. Plaque microvessels demonstrated that hypercholesterolemia (known predictor of plaque destabilization) impaired the lesion's mechanical We have also demonstrated that much of type I collagen properties. In hypercholesterolemic rabbits, the number of synthesis takes place in the vicinity of plaque microvessels type I procollagen-synthesizing cells was increased in both [24, 30] . Both endothelial cells and surrounding SMCs fibrous cap and shoulder regions of the plaque. However, (pericytes?) synthesized collagen. This might be because fibrous caps were collagen-rich, while shoulders were capillaries deliver serum-derived growth factors or because collagen-poor. At the same time, fibrous caps contained neovascularization is associated with production of growth numerous SMCs and almost no macrophages, while shoulfactors. On the other hand, type I collagen may be ders contained very limited numbers of SMCs and plenty important factor controlling plaque neoangiogenesis. Type of macrophages (Fig. 3) . As a result, collagen degradation I collagen induces endothelial cells to form capillary tubes prevailed in plaque shoulders and led to plaque mechanical in vitro [96] . It was proposed, that collagen fibrils serve as weakening [in preparation]. These results show that in our a template or cable onto which endothelial cells wrap model (1) hypercholesterolemia simultaneously stimulated themselves [97] .
plaque growth and destabilization, (2) destabilization was determined by the loss of cellular source rather than 5.5. Thrombus inhibition of collagen gene expression.
Our studies of human atherectomy coronary samples revealed close association between type I collagen gene expression and mural thrombi [30] in both primary and restenotic lesions. Exact reasons for such association are unclear. Thrombus may directly release growth factors and / or its fibrin constituent may work as a scaffold for migrating SMCs with a secondary activation of collagen synthesis. In general, colocalization of collagen synthesizing cells and thrombotic material may reflect a process of mural thrombus organization as a part of wound healing after asymptomatic plaque rupture thus providing ''growth through plaque rupture'' [17] .
Implications for plaque growth and rupture
Collagen degradation and synthesis take place simultaneously within the same plaques [85] . We are not aware of any study where both processes have been topographically correlated. However, overlaying the collagen synthesis data with the data on localization of collagendegrading activities could be instructive. Matrix metallop- Collagen fibers occupy about 80% of the section area in Conceptually, stimulation of collagen production in the samples of human coronary restenotic lesions [101] . atherosclerotic patients may be counterintuitive. If adNikkari et al. described elevated type I collagen synthesis ministered long term, such therapy might stabilize some in human carotid restenosis [85] . We were unable, howplaques, but accelerate an overall progression of atheroever, to find any dramatic difference in type I procollagen sclerosis and induce fibrosis of various organs. However, positive cell number in human primary and restenotic some compounds can stimulate collagen production, yet lesions [30] .
overall have an anti-atherosclerotic effect. For example, Reinjury of rat arterial lesions induced an increase in tamoxifen elevates TGF-b and suppresses diet-induced lesion size that was not associated with an increase in cell formation of lipid lesions in mouse aorta [113] . Although numbers [102] . Type I collagen gene expression was collagen synthesis was not evaluated in that report, the elevated 7 days after reinjury and returned to the control general knowledge of TGF-b biology predicts stimulation levels by 28 days. In rabbit double-injury model collagen of collagen production. synthesis was increased up to 4-10 times above control, as
In rabbits, lipid lowering by diet is sufficient to increase noted at 1, 2, and 4 weeks after angioplasty. The increase collagen content in atheroma via reduction of matrix in synthesis was accompanied by a significant increase in metalloproteinase-driven collagen degradation [114] . collagen content that coincided with the increase in crossTherefore, long term successful lipid lowering can stabilize sectional area [103] . Collagen synthesis and degradation plaques without pharmacological stimulation of collagen showed similar temporal profiles. Peak collagen synthesis synthesis. However, there may be some specific short-term and degradation occurred at 1 week after angioplasty. goals for boosting collagen production. Increase of colInterestingly, MMP inhibitor reduced both collagen degralagen breakdown was demonstrated in patients with dation and synthesis [104] . These data suggest that degramyocardial infarction treated with streptokinase or tissue dation of newly synthesized collagen is an important plasminogen activator [115, 116] . This life-saving intervenmechanism regulating collagen accumulation and that tion may increase the risk of plaque rupture. Stimulation of MMPs have an integral role in collagen turnover after collagen synthesis may help to counterbalance matrix balloon angioplasty.
breakdown. Increased synthesis, however, does not always mean Progress in clinical imaging makes identification of collagen accumulation and the luminal narrowing. Coats et ruptured or vulnerable plaques feasible in the nearest al. reported that collagen content was significantly lower in future [117] . Once the culprit plaque is identified, it may rabbit restenotic vessels [105]. Geary et al. argue that be selectively treated by means of gene therapy. We have lumen narrowing is caused in large part by changes in demonstrated in organ culture experiments, that areas of artery wall geometry rather than intimal mass per se [106] .
plaque rupture and thrombus are sites of predilection for They suggest that newly synthesized collagen may work as expression of recombinant genes, since these areas are a substrate for integrin-dependent wound contraction leaddevoid of collagen, and, therefore, do not possess an ing to luminal narrowing.
anatomical barrier for vector penetration [118] . Overexpression of genes stimulating collagen production has a potential to increase plaque strength. 7. Is collagen synthesis a reasonable target for antiatherosclerotic therapy?
8. Summary 7.1. Inhibition?
Uncontrolled collagen accumulation leads to arterial Traditionally, atherosclerosis was equated with luminal stenosis, while excessive collagen breakdown combined narrowing as a result of intimal growth. From that standwith inadequate synthesis weakens plaques thereby making point, any treatment inhibiting intimal thickening via them prone to rupture. Further studies focused on molecuinhibition of collagen synthesis should have beneficial lar regulation of collagen synthesis and degradation are effects. The list of compounds demonstrating ability to necessary to better understand the mechanisms of developinhibit collagen synthesis by SMCs, includes, but is not ment and complications of atherosclerosis. 21 limited to Ca channel blockers [107] , nitric oxide generators [58] , derivatized dextrans [108], tranilast [109] , protamine [110] , halofuginone [111] , and L-mimosine References [112] . However, inhibition of collagen production may shift the balance toward matrix breakdown thus making 
